BSE filing, NSE: SHREEGANES. Summary written from the filing by ALFA Finder's alert engine.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.47
- Market cap
- ₹18.74 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -38.9×Sector 47.2×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Q2 FY27 Results: Net Loss of ₹0.1 Cr
Shree Ganesh Biotech approved unaudited results for the half year ended September 2026. Half-year performance shows a net loss compared with last year's profit.
- Key figure
- Net loss ₹0.1 Cr
Shree Ganesh Bio-Tech (India) Board Meeting Date
Shree Ganesh Biotech will hold a board meeting on November 2, 2026 for unaudited results. The agenda is proposed and the meeting has not yet occurred.
Shree Ganesh Bio-Tech (India) Other Announcement
Company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Biotech (India) Limited held its 16th Annual General Meeting on 28th September 2026, where shareholders adopted financial statements and re-appointed a director.
Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Other debt & borrowing announcements
All →Shivamshree Businesses Debt & Borrowing: ₹10 Cr
Shivamshree Businesses approved fresh credit facilities of Rs. 10 crore from Bank of Baroda. The facilities include term loans and cash credit, secured by company assets.
- Value
- ₹10.00 Cr
Quint Digital Debt & Borrowing: ₹47 Cr
Quint Digital disclosed that its corporate guarantee for Quintype Solutions LLC became effective November 2, 2026. The guarantee covers USD 5 million, or up to USD 2.5 million under each MSA.
- Value
- ₹47.00 Cr
Mangal Credit And Fincorp Debt & Borrowing: ₹0.55 Cr
Mangal Credit paid ₹0.55 Crore of monthly interest on its secured NCDs, due 3 November 2026. No default or delay was reported.
- Value
- ₹0.55 Cr
Dar Credit & Capital Debt & Borrowing: ₹0.39 Cr
Dar Credit & Capital Limited has successfully paid interest totaling Rs. 0.39 Crore for two NCD series. The payments were made on November 3, 2026, for ISINs INE04Q907124 and INE04Q907157.
- Value
- ₹0.39 Cr
Blue Star Debt & Borrowing: ₹200 Cr
Blue Star Limited announced record dates for the maturity of listed Commercial Papers totaling Rs. 200 Crore. Redemption is scheduled across three tranches in November 2026.
- Value
- ₹200.0 Cr
Ugro Capital Debt & Borrowing: ₹23 Cr
UGRO Capital Limited has redeemed commercial papers worth Rs. 23.00 Crore upon maturity. The full redemption of 460 instruments was completed on November 3, 2026.
- Value
- ₹23.00 Cr